A New Perspective on the Renin-Angiotensin System

Area of Science:

• Cardiovascular Research
• Endocrinology
• Pharmacology

Background:

• Cardiovascular disease (CVD) remains the leading global cause of mortality.
• Hypertension is a significant health concern affecting all age groups.
• The renin-angiotensin-aldosterone system (RAAS) is crucial for blood pressure and electrolyte balance.

Purpose of the Study:

• To explore the role of alternative RAAS pathways in blood pressure regulation.
• To highlight the therapeutic potential of the ACE2/ang 1-7/MasR axis for hypertension.
• To discuss the limitations of current combination drug therapies for hypertension.

Main Methods:

• Review of current literature on RAAS pathways and their components.
• Analysis of the physiological effects of Angiotensin 1-7 (Ang 1-7) and Mas receptors.
• Examination of the therapeutic implications of ACE2/ang 1-7/MasR axis in hypertension.

Main Results:

• RAAS operates through endocrine, paracrine, autocrine, and intracrine mechanisms.
• Alternative RAAS pathways, involving peptides like Ang 1-7 and the Mas receptor, exhibit antihypertensive and cardioprotective effects.
• The ACE2/ang 1-7/MasR axis demonstrates vasodilatory, nitric oxide-releasing, and anti-inflammatory properties.

Conclusions:

• The ACE2/ang 1-7/MasR axis represents a promising therapeutic target for hypertension.
• Targeting alternative RAAS pathways may overcome the side effects associated with current combination drug therapies.
• Further research into the ACE2/ang 1-7/MasR axis could lead to novel hypertension treatments.